GIMEMA survey on the management of chronic myeloid leukemia patients in the third line and beyond: insights from Italian hematologists
{{output}}
Background: Approximately one-third of chronic myeloid leukemia (CML) patients may develop resistance and/or intolerance to the current therapies and need to switch to later lines of treatment. However, how to choose a later line... ...
